DiPerna Paul, a key executive at Modular Medical, Inc., has reported a significant stock option transaction. On October 29, 2026, DiPerna acquired 150,000 options to purchase common stock at an exercise price of $1.72 per share. This acquisition, filed with the SEC on November 9, 2026, underscores DiPerna's commitment to the company's future and aligns his interests with those of shareholders.

Modular Medical, Inc. operates in the surgical and medical instruments and apparatus sector. The company, incorporated in Nevada, has been making strides in developing innovative medical solutions. With this recent filing, DiPerna's role as President, Chief Financial Officer, and Treasurer is reinforced, as he takes on a more substantial ownership stake in the company.

The SEC filing indicates that the options granted will vest in a staggered manner, with one-third of the shares vesting on October 29, 2027, and the remaining shares vesting monthly thereafter. Following this transaction, DiPerna will own a total of 150,000 shares, reflecting a direct ownership stake in Modular Medical.

This move may have implications for both DiPerna and Modular Medical as they navigate the competitive landscape of the surgical and medical instruments industry. As executives increasingly align their compensation with company performance, such transactions can influence strategic decisions and investor confidence.

The filing does not specify what actions will follow this acquisition, but it highlights the ongoing trend of executive stock options as a tool for motivating leadership and driving company growth.